BA/BE Expertise
More than Traditional CRO Partner
Ordoclin brings extensive expertise in designing and executing complex Bioavailability (BA) and Bioequivalence (BE) studies, supported by strong scientific oversight and regulatory experience. Our teams manage complex study requirements, scientific correspondence, and regulatory interactions with a structured approach focused on data quality, compliance, and successful study execution.
From study planning and scientific communication to execution and regulatory submission, Ordoclin works closely with partners to navigate complex requirements and address challenges throughout the study lifecycle. Our experience across global regulatory pathways helps support efficient study progression and successful regulatory outcomes for generic drug development programs.
BA/BE Expertise in Numbers
Clinical, bioanalytical, and regulatory capabilities supporting modern generic drug development.
0+
BE Studies Completed
0+
BA/BE Biostatistics Supported
0
Biosimilar PK/PD Studies
0+
Validated Bioanalytical Methods
Therapeutic Areas We Support
Proven across diverse therapeutic areas.
Ordoclin conducts Bioavailability (BA) and Bioequivalence (BE) studies across diverse therapeutic areas, supporting generic and innovative products with therapeutic expertise and regulatory-focused study execution.
| Therapeutic Area | Studies Conducted | Therapeutic Area | Studies Conducted | ||
|---|---|---|---|---|---|
| Neuro-Psychiatry | 64 | General Medicine | 54 | ||
| Endocrinology & Metabolic Disorders | 34 | Hormones | 33 | ||
| Musculoskeletal | 30 | Cardiology | 28 | ||
| Pulmonology | 24 | Infectious Disease | 22 | ||
| Gastroenterology | 26 | Ophthalmology | 5 |
Dosage Form Research Expertise
Supporting BA/BE studies across diverse drug products.
Our BA/BE experience spans a broad range of dosage forms, including oral, injectable, inhalation, topical, and biosimilar products, supported by integrated clinical, bioanalytical, and regulatory operations.
GLP-Certified Bioanalytical Laboratory
Where quality becomes confidence.
Ordoclin's GLP-certified bioanalytical laboratory is equipped with LC-MS/MS systems, including Sciex 4500 and Sciex 6500 platforms, supporting high-sensitivity bioanalytical testing for BA/BE studies, pharmacokinetic (PK) analysis, and clinical research programs. With 200+ validated bioanalytical methods and annual throughput exceeding 10,000 samples, our expanding laboratory infrastructure is designed to support increasing analytical demand and complex development programs.
Specialist Assay Capabilities
Our method portfolio extends well beyond standard assays:
- Assays for highly unstable molecules
- Protein-bound & unbound assays
- Light-sensitive assay handling
- Ultra-trace detection assays
- Chiral assays
- Endogenous assays
- Conjugated & unconjugated assays
- Hormonal product assays
- Liposomal-encapsulated & unencapsulated assays
- Vitamin product assays
- Fat analysis in food and feces
- Bisphosphonate assay
BA/BE Study Workflow
Structured processes supporting clinical conduct, bioanalysis, and regulatory delivery.
Our integrated BA/BE study workflow connects clinical operations, bioanalytical testing, pharmacokinetic analysis, and biostatistics within a single operational framework. With dedicated project oversight, streamlined communication, and in-house expertise, studies progress efficiently from protocol development to submission-ready data.
Supporting Global Regulatory Submissions
Data designed for global submissions.
Our BA/BE studies have supported submissions to leading regulatory authorities worldwide, enabling partners to extend the value of a single study across multiple international markets.
| Primary Submission Agency | Extended To (Examples) |
|---|---|
| US FDA | Health Canada, MHRA, NMPA, NPRA, 20+ additional countries |
| EMA | Health Canada, MHRA, and other ROW countries |
| Health Canada | Iraq, MHRA, NPRA, SAHPRA |
| TGA (Australia) | Colombia, NPRA, Taiwan |
Quality Management & Compliance
Quality without compromise.
Ordoclin's QMS is built to ICH-GCP E6 R3 standards and governs every aspect of BA/BE study conduct — from document control and deviation management through CAPA, audit scheduling, and third-party monitoring.
Fully integrated electronic system with eCRF, eTMF, eMonitoring & eProject Tracking tools, equipment management, and computer systems validation integrated into every study.
Regulatory Alignment
- ICH-GCP E6 R3 · FDA · EMA · CDSCO
Governance
- Policies & agreements · Risk & audit management · 3rd-party monitoring
Process Control
- QMS/DMS 21 CFR Part 11 · SOPs · Document control · Change control
Continuous Improvement
- Training & eLearning
- Deviation & CAPA
- Live project tracking
AI-Integrated & Fully Electronic Clinical Trial Systems
Smarter workflows. Greater visibility. Faster execution.
Ordoclin operates a fully electronic, AI-enabled clinical research ecosystem integrating clinical operations, bioanalytical testing, data management, and project oversight within a single connected platform. Supported by 21 CFR Part 11-compliant systems, real-time data capture, validated workflows, and digital audit trails, our infrastructure is designed to improve operational efficiency, strengthen data integrity, and support submission-ready clinical research.
- Electronic Case Report Forms (eCRF)
- Electronic Trial Master File (eTMF)
- Real-Time Project Tracking & Sponsor Dashboards
- e-Monitoring & Remote Study Oversight
- Automated Sample Inventory Management
- Computer Systems Validation (CSV)
- 21 CFR Part 11 Electronic Signatures & Audit Trails
- CDISC-Compliant Data Outputs
- AI-Assisted Subject Safety Monitoring
- Predictive PK Modelling & Data Review
- Intelligent Data Query Management
- Bioanalytical Performance Monitoring
- Sponsor-Facing Live Analytics
- AI-Supported Reporting & Documentation
AI-Enabled Clinical Operations
AI where it creates real value.
Artificial intelligence is applied where automation, pattern recognition, and real-time insights can improve study efficiency while maintaining human oversight for clinical and regulatory decision-making.
Digital Workflows Across Every Study Stage
One workflow. Complete oversight.
Every stage of study execution is managed through validated electronic systems with complete audit trails, ensuring data integrity, traceability, and regulatory compliance. The workflow below illustrates how clinical trials progress through Ordoclin's integrated digital research environment.
Precision PK Sampling Management
−Automated scheduling tools support protocol-defined PK sampling windows, with real-time alerts and electronic timestamp capture to improve sampling accuracy and protocol compliance.
- Automated sampling alerts
- Electronic timestamp capture
- Protocol deviation tracking
- Real-time sample monitoring
Crossover Period Management
+Electronic randomization and trial supply management systems support crossover study execution, treatment allocation tracking, washout period management and drug accountability.
- Electronic randomization (RTSM/IxRS)
- Treatment allocation audit trail
- Washout period tracking
- Drug accountability records
Regulatory-Ready Biostatistics Output
+Validated statistical workflows support PK analysis, bioequivalence assessment and submission-ready datasets aligned with global regulatory requirements.
- Statistical Analysis Plans (SAP)
- SAS-validated analysis programs
- CDISC-compliant datasets
- Submission-ready tables & listings
Remote Monitoring & e-Source Verification
+Secure sponsor access supports remote study oversight, electronic source data verification and real-time monitoring activities.
- Secure sponsor portal access
- Electronic source data verification
- Risk-based monitoring support
- Real-time query tracking
Digital Capabilities for BA/BE Studies
AI-Driven Efficient Digital Platform
BA/BE studies demand tight, time-critical workflows, particularly around PK sampling windows, sample stability, and the statistical precision required for regulatory acceptance. Ordoclin's digital systems are configured specifically for these demands.
A Trusted Partner for BA/BE Studies
One partner. Complete oversight.
Ordoclin supports BA/BE programs through a combination of experienced study teams, dedicated infrastructure, and integrated scientific capabilities. From protocol development through final reporting, partners benefit from a single partner focused on quality, compliance, and operational efficiency.
- Clinical, Analytical & Statistical Expertise Under One Roof
- Dedicated BA/BE Clinical & Laboratory Facilities
- Experience Across Multiple Dosage Forms
- Global Regulatory Submission Support
- Validated Digital & Quality Systems
- Submission-Ready Data Packages
